Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Rating) have earned an average rating of “Hold” from the twenty research firms that are covering the company, MarketBeat reports. Nine analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $8.31.
A number of analysts have commented on GDRX shares. DA Davidson lowered their price target on GoodRx to $5.00 in a research report on Tuesday, November 15th. JPMorgan Chase & Co. raised GoodRx from an “underweight” rating to a “neutral” rating and lowered their price target for the stock from $10.00 to $8.00 in a research report on Friday, November 4th. Barclays lowered their price target on GoodRx from $9.00 to $8.00 and set an “overweight” rating for the company in a research report on Wednesday. Truist Financial lowered their price target on GoodRx to $6.00 in a research report on Wednesday, November 16th. Finally, Citigroup began coverage on GoodRx in a research report on Thursday, December 1st. They set a “buy” rating and a $7.00 price target for the company.
GoodRx Stock Up 2.3 %
GoodRx stock opened at $5.30 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 10.34 and a quick ratio of 10.34. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of -31.17, a PEG ratio of 13.57 and a beta of 0.71. GoodRx has a 1-year low of $3.82 and a 1-year high of $30.89. The business has a fifty day moving average price of $4.94 and a 200-day moving average price of $5.55.
Institutional Investors Weigh In On GoodRx
GoodRx Holdings, Inc, through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States.
- Get a free copy of the StockNews.com research report on GoodRx (GDRX)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for GoodRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoodRx and related companies with MarketBeat.com's FREE daily email newsletter.